EBITDA-linked remuneration and restricted stock compensation
First written in FY2022. 8 of 12 entries say "Advanced", first in FY2023-Q1. Latest entry: 2026-07-24.
11 other companies' latest entry also says "Achieved".
- FY2026AdvancedAnnual report
「These stock acquisition rights may be exercised only if the Company’s consolidated adjusted EBITDA exceeds ¥16,000 million in any fiscal year from the fiscal year ending March 2027 through the fiscal year ending March 2030.」
The annual disclosure provided details of the grant of Series 4 stock acquisition rights equivalent to 1,567,100 shares and the plan under which exercise is conditional on consolidated adjusted EBITDA exceeding ¥16,000 million in any fiscal year from the fiscal year ending March 2027 through the fiscal year ending March 2030. - 2026-06-03RaisedGeneral Meetings of Shareholders
「We request approval to set the total number of the company's common shares issued or disposed of under this system through the no-cost allotment method or the in-kind contribution method at no more than 160,000 shares per year, and the total amount of the company's common shares issued or disposed of for restricted stock for eligible directors at no more than ¥100 million per year, of which the portion for outside directors will be limited to no more than 8,000 shares and ¥5 million per year.」
The annual limit for restricted stock compensation was raised from no more than ¥40 million to no more than ¥100 million, and a separate limit for outside directors was presented. - FY2026-H1AdvancedAnnual report
「Recipients of these stock acquisition rights may exercise them only if the Company’s consolidated adjusted EBITDA exceeds ¥16,000 million in any fiscal year from the fiscal year ending March 2027 through the fiscal year ending March 2030.」
A new performance-linked incentive was established under which 15,671 Series 4 stock acquisition rights were granted to directors, employees and others, with exercise conditional on consolidated adjusted EBITDA exceeding ¥16,000 million in any fiscal year from the fiscal year ending March 2027 through the fiscal year ending March 2030. - FY2025RaisedAnnual report
「The total performance-linked remuneration, or profit-linked salary, for executive directors is capped at ¥20 million. Based on the above policy, it will be paid by applying achievement coefficients corresponding to the following achievement rates against the Company’s EBITDA target for the fiscal year ending March 2025, where EBITDA is operating income plus depreciation and amortization plus amortization of goodwill.」
The cap on total performance-linked remuneration was increased from ¥12 million to ¥20 million, and a payment structure based on coefficients corresponding to achievement of the EBITDA target for the fiscal year ending March 2025 was presented. In addition, 20,656 restricted shares were delivered during the fiscal year under review. - FY2025-H1AdvancedAnnual report
「This represents an increase resulting from the issuance of new shares as restricted stock compensation.」
On 26 July 2024, the Company issued 5,771 shares as restricted stock compensation, advancing implementation of the plan for 4 directors and 1 employee. - FY2024AdvancedAnnual report
「The target EBITDA (operating profit + depreciation and amortisation + goodwill amortisation), used as the performance-linked compensation metric for the fiscal year, was ¥4,750 million, while actual EBITDA was ¥5,841 million. Performance-linked compensation has therefore been paid as described above.」
Performance-linked remuneration based on achievement of the EBITDA target for the fiscal year ended March 2024 was paid. In addition, 8,210 restricted shares were delivered to 5 directors and other personnel during the fiscal year under review. - FY2024-Q1AdvancedAnnual report
「Pursuant to a resolution of the Board of Directors held on 28 June 2023, the Company issued 10,555 new shares as restricted stock compensation effective 28 July 2023.」
The issuance of 10,555 new shares under the restricted stock compensation plan was carried out, advancing the plan from the resolution to introduce it to the stage of actual share delivery. - FY2023AdvancedAnnual report
「The total performance-linked remuneration, or profit-linked salary, for executive directors is capped at ¥12 million. Based on the above policy, it will be paid by applying achievement coefficients corresponding to the following achievement rates against the Company’s EBITDA target for the fiscal year ending March 2023, where EBITDA is operating income plus depreciation and amortization plus amortization of goodwill.」
Actual EBITDA was ¥4,251 million against the target of ¥3,696 million for the fiscal year ending March 2023, and performance-linked remuneration tied to target achievement was paid. - FY2023-Q1AdvancedAnnual report
「The Company resolved to issue new shares as restricted stock compensation, and the payment procedures were completed on 28 July 2022.」
Following the resolution to introduce the restricted stock compensation plan, the issuance and payment for 9,140 common shares were completed on 28 July 2022, advancing the plan to the implementation stage. - FY2022First statedAnnual report
「A bonus calculated according to the degree of achievement against the EBITDA target for each fiscal year, where EBITDA is operating income plus depreciation and amortization, is paid annually at a specified time. In addition, at the 50th annual general meeting of shareholders held on 28 June 2022, the Company resolved to introduce a restricted stock compensation plan to promote sustainable enhancement of corporate value and further value sharing between directors and shareholders.」
Performance-linked remuneration is tied to achievement of the EBITDA target, with actual EBITDA of ¥3,212 million against the target of ¥3,168 million for the fiscal year under review. A restricted stock compensation plan has also been introduced as a medium- to long-term incentive.